Abstract
IN 1936, Peacock1 observed that animals receiving intravenous injections of 3: 4-benzpyrene excreted in the bile an alkali-soluble product (BPX) possessing specific fluorescence bands which differed from those of the parent hydrocarbon. Subsequent investigations by Chalmers2,3 demonstrated the existence of a similar phenolic derivative in the fæces, and this led to its isolation and purification. From recent crystallographic analysis4, this metabolic product is considered to be a monohydroxy-benzpyrene.
Similar content being viewed by others
References
Peacock, P. R., Brit. J. Exp. Path., 17, 164 (1936).
Chalmers, J. G., Biochem. J., 32, 271 (1938).
Chalmers, J. G., Biochem. J., 34, 678 (1940).
Chalmers, J. G., and Crowfoot, D., Biochem. J., 35, 1270 (1941).
Warren, F. L., Proc. Biochem. Soc. Chem. and Ind., (in the press, 1942).
Berenblum, I., and Schoental, R., Biochem. J., (in the press, 1942).
Vollmann, H., Becher, H., Corell, M., and Streek, H., Ann. Chem. 531, 1 (1937).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
BERENBLUM, I., SCHOENTAL, R. Metabolic Products of 3: 4-Benzpyrene. Nature 149, 439–440 (1942). https://doi.org/10.1038/149439b0
Issue Date:
DOI: https://doi.org/10.1038/149439b0
- Springer Nature Limited